EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Role of Kynurenines Produced by Indolamine-2,3-Dioxygenase 1 in Sepsis

Simon Lerch, Joerg C Schefold, Thibaud Spinetti

Pharmacology · 2022 · 107 (7-8) · 359-367

DOI: 10.1159/000523965 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology, online erschienen am 12.04.2022. Verfasst von Simon Lerch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Kynurenine, Sepsis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: The enzyme indolamine-2,3-dioxygenase 1 (IDO1) is the rate-limiting enzyme of the kynurenine (KYN) pathway and metabolizes the essential amino acid tryptophan to KYNs. The depletion of tryptophan and the generation of KYNs were shown to be involved in the global downregulation of the immune system during the later stages of sepsis, also referred to as sepsis-associated immunosuppression. Summary: The generation of KYNs by IDO1 leads to a depletion of effector T cells, including increased rate of apoptosis, decreased ability of T-cell proliferation and activation, and the generation of FoxP3+ regulatory T cells. Furthermore, KYN was shown a potent vasorelaxant during inflammation-induced hypotension. Experimental studies in murine sepsis models and in humans show promising data for using the activation of IDO1 both as a prognostic marker and potential drug target in sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KynurenineSepsisAnimalsHumansIndoleamine-Pyrrole 2,3,-DioxygenaseMiceT-Lymphocytes, RegulatoryTryptophan

Stichwörter der Autor:innen

Indolamine-2,3-dioxygenase 1Indolamine-2,3-dioxygenase 1 activationKynurenineKynurenine pathwaySepsisSepsis-associated immunosuppressionTryptophan

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseKynurenineTryptophan

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, joerg.schefold@insel.ch.

Zitieren

APA

Lerch, S., Schefold, J. C., & Spinetti, T. (2022). The Role of Kynurenines Produced by Indolamine-2,3-Dioxygenase 1 in Sepsis. Pharmacology, 107(7-8), 359-367. https://doi.org/10.1159/000523965

Vancouver

Lerch S, Schefold JC, Spinetti T. The Role of Kynurenines Produced by Indolamine-2,3-Dioxygenase 1 in Sepsis. Pharmacology. 2022;107(7-8):359-367. doi:10.1159/000523965

BibTeX
@article{Lerch2022,
  author = {Lerch, Simon and Schefold, Joerg C and Spinetti, Thibaud},
  title = {The Role of Kynurenines Produced by Indolamine-2,3-Dioxygenase 1 in Sepsis},
  journal = {Pharmacology},
  year = {2022},
  volume = {107},
  number = {7-8},
  pages = {359--367},
  doi = {10.1159/000523965}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche